THE USE OF SEMAGLUTIDE (ANALOG OF GLP-1) IN THE TREATMENT OF OBESITY (Atena Editora)

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributor.authorGALIASSI, GIOVANA ELISA ROSA-
Autor(es): dc.contributor.authorCRUZ, PAULO OCTÁVIO NADAF POUSO TÔRRES-
Autor(es): dc.contributor.authorFIGUEIREDO, CHRISTIANE YULE DE BARROS-
Autor(es): dc.contributor.authorBEZERRA, THAYANNE RYSIA GOMES-
Autor(es): dc.contributor.authorMARTINS, ANDRELA COLOMBO-
Autor(es): dc.contributor.authorSILVA, LUCIANA MARQUES DA-
Data de aceite: dc.date.accessioned2022-08-26T19:47:42Z-
Data de disponibilização: dc.date.available2022-08-26T19:47:42Z-
Data de envio: dc.date.issued2022-08-10-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/714807-
Resumo: dc.description.abstractObesity is a complex pathology that affects virtually all stages of life, regardless of socioeconomic groups. GLP-1 analogues are potentially promising drugs for weight loss in obese or overweight adults and at least one comorbidity. An integrative review of the use of the GLP-1 analogue semaglutide in the treatment of obesity and weight loss therapy was reviewed, analyzing the STEP (Semaglutide Treatment Effect in People with Obesity) study.pt_BR
Idioma: dc.language.isoenpt_BR
Palavras-chave: dc.subjectPHARMACOLOGICALpt_BR
Título: dc.titleTHE USE OF SEMAGLUTIDE (ANALOG OF GLP-1) IN THE TREATMENT OF OBESITY (Atena Editora)pt_BR
Tipo de arquivo: dc.typelivro digitalpt_BR
Aparece nas coleções:Livros digitais